Literature DB >> 25472679

Establishment of the cancer prevention study II nutrition cohort colorectal tissue repository.

Peter T Campbell1, Anusila Deka2, Peter Briggs2, Mine Cicek3, Alton B Farris4, Mia M Gaudet2, Eric J Jacobs2, Christina C Newton2, Alpa V Patel2, Lauren R Teras2, Stephen N Thibodeau3, Lori Tillmans3, Susan M Gapstur2.   

Abstract

BACKGROUND: To better understand colorectal cancer etiology and prognosis, archived surgical tissues were collected from Cancer Prevention Study II (CPS-II) Nutrition Cohort participants who were diagnosed with colorectal cancer. Herein, the methodology for this collection is described to help inform other efforts to collect tissues.
METHODS: The main components to accruing tissue were: (i) obtaining consent from participants or next-of-kin; (ii) contacting hospitals to request materials; and (iii) pathology review and laboratory processing.
RESULTS: In CPS-II, we identified 3,643 participants diagnosed with colorectal cancer between 1992/1993 and 2009. Of these, tissue could not be sought from cases verified through state cancer registry linkage (N = 1,622), because of insufficient information on tissue location. We sought tissue from the 2,021 cases verified using medical records, and received tissue from 882. When hospitals were contacted within 10 years of diagnosis, we received 87% of tissue materials; beyond that 10-year mark, we received 32%. Compared with the 2,761 colorectal cancer cases without tissue, the 882 cases with tissue were more likely to be alive, diagnosed more recently during follow-up, and had less-advanced staged disease. Cases with and without tissues were similar with respect to age at diagnosis, smoking, body mass index, physical activity, and other epidemiologic factors.
CONCLUSIONS: Some of the most important elements in forming a tissue repository included having the cases' hospital contact and surgical accession information as well as contacting patients/next-of-kin and hospitals within 10 years of surgery. IMPACT: This tissue repository will serve as an important resource for colorectal cancer studies. See all the articles in this CEBP Focus section, "Biomarkers, Biospecimens, and New Technologies in Molecular Epidemiology." Cancer Epidemiol Biomarkers Prev; 23(12); 2694-702. ©2014 AACR. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 25472679     DOI: 10.1158/1055-9965.EPI-14-0541

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  17 in total

1.  The Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial Pathology Tissue Resource.

Authors:  Claire S Zhu; Wen-Yi Huang; Paul F Pinsky; Christine D Berg; Mark Sherman; Kelly J Yu; Danielle M Carrick; Amanda Black; Robert Hoover; Petra Lenz; Craig Williams; Laura Hawkins; Matthew Chaloux; Susan Yurgalevitch; Sunitha Mathew; Amy Miller; Vanessa Olivo; Asia Khan; Shannon M Pretzel; Deborah Multerer; Patricia Beckmann; Karen G Broski; Neal D Freedman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-09-15       Impact factor: 4.254

Review 2.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

Review 3.  Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.

Authors:  Tsuyoshi Hamada; NaNa Keum; Reiko Nishihara; Shuji Ogino
Journal:  J Gastroenterol       Date:  2016-10-13       Impact factor: 7.527

4.  Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.

Authors:  Shuji Ogino; Reiko Nishihara; Tyler J VanderWeele; Molin Wang; Akihiro Nishi; Paul Lochhead; Zhi Rong Qian; Xuehong Zhang; Kana Wu; Hongmei Nan; Kazuki Yoshida; Danny A Milner; Andrew T Chan; Alison E Field; Carlos A Camargo; Michelle A Williams; Edward L Giovannucci
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

Review 5.  Proceedings of the third international molecular pathological epidemiology (MPE) meeting.

Authors:  Peter T Campbell; Timothy R Rebbeck; Reiko Nishihara; Andrew H Beck; Colin B Begg; Alexei A Bogdanov; Yin Cao; Helen G Coleman; Gordon J Freeman; Yujing J Heng; Curtis Huttenhower; Rafael A Irizarry; N Sertac Kip; Franziska Michor; Daniel Nevo; Ulrike Peters; Amanda I Phipps; Elizabeth M Poole; Zhi Rong Qian; John Quackenbush; Harlan Robins; Peter K Rogan; Martha L Slattery; Stephanie A Smith-Warner; Mingyang Song; Tyler J VanderWeele; Daniel Xia; Emily C Zabor; Xuehong Zhang; Molin Wang; Shuji Ogino
Journal:  Cancer Causes Control       Date:  2017-01-17       Impact factor: 2.506

Review 6.  Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.

Authors:  Shuji Ogino; Jonathan A Nowak; Tsuyoshi Hamada; Amanda I Phipps; Ulrike Peters; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Marios Giannakis; Wendy S Garrett; Mingyang Song
Journal:  Gut       Date:  2018-02-06       Impact factor: 23.059

7.  Follow-up of a Large Prospective Cohort in the United States Using Linkage With Multiple State Cancer Registries.

Authors:  Eric J Jacobs; Peter J Briggs; Anusila Deka; Christina C Newton; Kevin C Ward; Betsy A Kohler; Susan M Gapstur; Alpa V Patel
Journal:  Am J Epidemiol       Date:  2017-10-01       Impact factor: 4.897

8.  A Meta-Regression Method for Studying Etiological Heterogeneity Across Disease Subtypes Classified by Multiple Biomarkers.

Authors:  Molin Wang; Aya Kuchiba; Shuji Ogino
Journal:  Am J Epidemiol       Date:  2015-06-26       Impact factor: 4.897

9.  Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.

Authors:  Kentaro Inamura; Mingyang Song; Seungyoun Jung; Reiko Nishihara; Mai Yamauchi; Paul Lochhead; Zhi Rong Qian; Sun A Kim; Kosuke Mima; Yasutaka Sukawa; Atsuhiro Masuda; Yu Imamura; Xuehong Zhang; Michael N Pollak; Christos S Mantzoros; Curtis C Harris; Edward Giovannucci; Charles S Fuchs; Eunyoung Cho; Andrew T Chan; Kana Wu; Shuji Ogino
Journal:  J Natl Cancer Inst       Date:  2015-11-23       Impact factor: 13.506

Review 10.  Integration of molecular pathology, epidemiology and social science for global precision medicine.

Authors:  Akihiro Nishi; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Andy S Tan; Ichiro Kawachi; Shuji Ogino
Journal:  Expert Rev Mol Diagn       Date:  2015-12-04       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.